Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PANTODELL-DSR
- Development stage
- Unknown
- Lead developer
- Cadell
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
PANTODELL-DSR is a fixed-dose combination medication developed and marketed by Cadell Healthcare for the management of acid-related gastrointestinal disorders. It contains pantoprazole, a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, and domperidone, a peripheral dopamine D2 receptor antagonist. Domperidone acts as a prokinetic agent, increasing gastrointestinal motility and providing antiemetic effects by blocking dopamine receptors in the chemoreceptor trigger zone. This combination is primarily indicated for gastroesophageal reflux disease (GERD), dyspepsia, and associated symptoms such as heartburn, nausea, and bloating. It is formulated as an oral capsule, with domperidone typically provided in a sustained-release form to ensure prolonged efficacy.
- Brand names
- PANTODELL-DSRPantodell DSR Capsule
- Other names
- Pantoprazole + Domperidone
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)DRD2 (Dopamine D2 Receptor)
Beyond the preview
Go deeper on PANTODELL-DSR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PANTODELL-DSR.